Bibliografía 

2. Blondhein SH, Margoliash E, Shafrir E. A simple test for myohemoglobinuria (myoglobinuria). JAMA 1958;167:453-4

3. Brodine CE, Vertrees KM. Differentiation of myoglobinuria from hemoglobinuria. In: Sunderman FW, Sunderman FW Jr, eds. Hemoglobin--its precursors and metabolites. Philadelphia: JB Lippincott, 1964:90-3.

4. Fink DJ, Petz LD, Black MD. Serum haptoglobin: a valuable diagnostic aid in suspected hemolytic transfusion reactions. JAMA 1967;199:615-8.

5. Langley JW, McMahan M, Smith N. A ninemonth transfusion service experience with low-ionic strength saline (LISS) solution. Am J Clin Pathol 1980;73:99-103.

6. Lalezari P, Jiang AF. The manual polybrene test--a simple and rapid procedure for detection of red cell antibodies. Transfusion 1980;20:206-11.

7. Baldwin ML, Barrasso C, Ness PM, Garratty G. A clinically significant erythrocyte ntibody detectable only by 5~Cr survival studies. Transfusion 1983;23:40-4.

8. Pineda AA, Brzica SM Jr, Taswell HF. Hemolytic transfusion reaction: recent experience in a large blood bank. Mayo Clin Proc 1978;53:378-90.

9. Goldfinger D. Acute hemolytic transfusion reactions--a fresh look at pathogenesis and considerations regarding therapy. Transfusion 1977;17:85-98.

10. Bick RL. The clinical significance of fibrinogen degradation products. Sem Thromb Hemost 1984;8:302-30.

11. Mollison PL Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 8th ed. London: Blackwell Scientific Publications, 1987:605-7.

12. Goldberg Ll. Cardiovascular and renal actions of dopamine: potential clinical application. Pharm Rev 1972;24:1-29.

13. Stewart JW, Mollison PL. Rapid detruction of apparently compatible cells. Br Med J 1959;1:1274-5.

14. Fudenberg HH, Allen FH. Transfusion reactions in the absence of demonstrable incompatibility. N Engl J Med 1957;256:1180-4.

15. Myhre BA. Fatalities from blood transfusion. JAMA 1980;244:1333-5.

16. Honig CL, Bove JR. Transfusion-associated fatalities: a review of Bureau of Biologics reports 1976-1978. Transfusion 1980;20:653-61.

17. Brittingham TE, Chaplin H. Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets. JAMA 1957;165:819-25.

18. Thulstrup H. The influence of leukocyte and thrombocyte incompatibility on non-haemolytic transfusion reactions: a retrospective study. Vox Sang 1971;21:233-50.

19. Kevy SV, Schmidt PJ, McGinniss MH, Workman WG. Febrile, non-hemolytic transfusion reactions and the limited role of leukoagglutinin in their atiology. Transfusion 1962;2:7-16.

20. Menitove JE, McElligott MC, Aster RH. Febrile transfusion reaction: what blood component should be given next? Vox Sang 1982;42:318-21.

21. Braude Al. Transfusion reactions from contaminated blood: their recognition and treatment. N Engl J Med 1958,258:1289-9.

22. Braine HG, Kickler TS, Charache P, et al. Bacterial sepsis secondary to platelet transfusion: an adverse effect of extended storage at room temperature. Transfusion 1986;26:391-3.

23. Heal JM, Singal S, Sardisco E, Mayer T. Bacterial proliferation in platelet concentrates. Transfusion 1986,26:388-90.

24. Anderson KC, Lew MA, Gorgone BC, Martel J, Leamy CB, Sullivan B. Transfusion-related sepsis after prolonged platelet storage. Am J Med 1986;81:405-11.

25. Tabor E, Gerety RJ. Five cases of pseudomonas sepsis transmitted by blood transfusions. Lancet 1984,1:1403.

26. Buchholz DH, Young VM, Friedman NR, Reilly JA, Mardiney MR Jr. Detection and quantitations of bacteria in platelet products stored at ambient temperature. Transfusion 1973;13:268-75.

27. Wright DC, Selss IF, Vinton KJ, Pierce RN. Fatal Yersinia enterocolltlca sepsis after blood transfusion. Arch Pathol Lab Med 1985;109:1040-2.

28. Elin RJ, Lundberg WB, Schmidt PJ. Evaluation of bacterial contamination in blood processing. Transfusion 1975,15:260-5.

29 Vyas GN, Holmdahl L, Perkins HA, Fudenberg HH. Serologic specificity of human anti-lgA and its significance in transfusion. Blood 1969;34:573-81.

30. Yap PL, Pryde EAD, McClelland DBL. IgA content of frozen-thawed-washed red blood cells and blood prducts measured by radioimmunoassay. Transfusion 1982;22:36-8.

31. Wells JV, King MA. Adverse reactions to human plasma proteins. Anaesth Intens Care 1980;8:139-44.

32. Marriott HL, Kekwick. Volume and rate in blood transfusion for relief of anemia. Br Med J 1980; 1:1043-6.

33. Ward HN. Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med 1970;73:689-94.

34. Dubois M, Lotze MT, Diamond WJ, Kim Yd, Flye MW, Macnamara TE. Pulmonary shunting during leukoagglutinin-induced noncardiac pulmonary edema. JAMA 1980;244:2186-9.

35 Popovsky MA, Moore SB. Diagnostic and pathogenic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573-7.

36. Thompson JS, Severson CD, Parmely MJ, Marmorstein BL, Simmons A. Pulmonary "hypersensitivity" reactions induced by transfusion of non-HLA leukoagglutinins. N Engl J Med 1971;284:1120-5.

37. Kernoff PBA, Durrant IJ, Rizza CR, Wright FW. Severe allergic pulmonary edema after plasma transfusion. Br J Haematol 1972;23:777-81.

38. Higby DJ, Burnett D. Granulocyte transfusions: current status. Blood 1980;55:2-8.

39. Jacob HS, Craddock PR, Hammerschmidt DE, Moldow CF. Complement-induced granulocyte aggregation. N Engl J Med 1980;302:789-94.

40 Hammerschmidt DE, Weaver J, Hudson LD, Craddock PR, Jacob HS. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Lancet 1980;1:947-9.

Higging Mj, Klein HG. Massive Transfusión in the Intensive Care Unit. J. Intensive Care Med 1989; 4-221-233.

42. Richrad H. Walke, MD. Manual técnico AABB. 10ª edic. 1990.

43. Douglas W Huetis, Joseph R Bove, Shirley Busch. Transfusión sanguìnea. Editorial Salvat, 1985.